Removing the ‘What If’s’ from Cancer

Current cancer screenings are limited, only detecting a small number of cancers early. Many cancers are undetected and unchecked, left to their own destructive devices for far too long. Without effective early diagnosis, cancer can advance to later stages that require burdensome treatments resulting in uncertain, and often devastating, outcomes.



GRAIL is a biotechnology company that developed the Galleri™ multi-cancer early detection test.

By using advanced DNA sequencing-based technology with a single blood draw, Galleri™ efficiently uses one blood test to screen for over 50 cancers. By detecting most cancer types earlier, these results empower people to proactively protect their health.



GRAIL partnered with us to help establish and launch the Galleri™ test and encourage both patients and healthcare providers to check for cancer routinely. The goal was to raise awareness that this simple blood test is now an option and entice patients to request it from their physicians.



We developed a concept that focused on removing the various uncertainties around potentially having cancer. The Galleri test removes the ‘What ifs’. It has the potential to remove the worries and questions around the possibility of having cancer. It can detect multiple types of cancer early and offer peace of mind.



We pulled this concept through in a video that sheds light on the emotional journey many patients and their loved ones experience over the course of the fight against cancer. We follow the storyline of a female who at first seems nostalgic over her late husband. When she steps outside and sees her husband happy and working diligently in their garden, we are uplifted by this reality that was made possible with Galleri™. Diagnosing cancer as early as possible can save lives.